HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mukesh K Nyati Selected Research

beta-Galactosidase (Lactaid)

2/2003Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mukesh K Nyati Research Topics

Disease

31Neoplasms (Cancer)
03/2024 - 04/2002
9Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 01/2006
5Colorectal Neoplasms (Colorectal Cancer)
02/2019 - 04/2002
4Squamous Cell Carcinoma of Head and Neck
12/2016 - 04/2010
4Prostatic Neoplasms (Prostate Cancer)
10/2012 - 02/2009
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 10/2015
3Lung Neoplasms (Lung Cancer)
01/2020 - 01/2013
3Carcinoma (Carcinomatosis)
01/2006 - 02/2003
2Carcinogenesis
12/2016 - 05/2016
1Oropharyngeal Neoplasms
01/2023
1Rectal Neoplasms (Rectal Cancer)
02/2019
1Radiation Pneumonitis
07/2017
1Pneumonia (Pneumonitis)
07/2017
1Squamous Cell Neoplasms (Squamous Cell Cancer)
09/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2011
1Adenocarcinoma of Lung
07/2011
1Lymphoma (Lymphomas)
04/2010
1Neoplasm Metastasis (Metastasis)
02/2009
1Glioblastoma (Glioblastoma Multiforme)
09/2007
1Inborn Urea Cycle Disorders
09/2007
1Weight Loss (Weight Reduction)
04/2007
1Ataxia Telangiectasia (Louis Bar Syndrome)
12/2006
1Colonic Neoplasms (Colon Cancer)
02/2003

Drug/Important Bio-Agent (IBA)

11ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2004
7Proteins (Proteins, Gene)FDA Link
08/2021 - 11/2009
6Cetuximab (Erbitux)FDA Link
01/2023 - 04/2007
6Phosphotransferases (Kinase)IBA
08/2021 - 01/2004
4Tyrosine Kinase InhibitorsIBA
01/2020 - 04/2007
3Cisplatin (Platino)FDA LinkGeneric
01/2015 - 04/2010
3geldanamycinIBA
02/2014 - 08/2012
3GemcitabineFDA Link
06/2011 - 01/2006
3EnzymesIBA
01/2010 - 04/2002
3Fluorouracil (Carac)FDA LinkGeneric
07/2006 - 04/2002
2(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
10/2020 - 08/2012
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 09/2013
2Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2016 - 08/2012
2Small Interfering RNA (siRNA)IBA
12/2016 - 07/2011
2Peptides (Polypeptides)IBA
02/2014 - 09/2013
2Biomarkers (Surrogate Marker)IBA
09/2013 - 02/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2011 - 10/2011
2Messenger RNA (mRNA)IBA
07/2011 - 02/2003
2Sarcosine (Methylglycine)IBA
09/2010 - 02/2009
2Gefitinib (Iressa)FDA Link
04/2007 - 01/2006
2ProdrugsIBA
02/2003 - 04/2002
2Cytosine DeaminaseIBA
02/2003 - 04/2002
2Flucytosine (Ancobon)FDA Link
02/2003 - 04/2002
1LectinsIBA
03/2024
1Antiviral Agents (Antivirals)IBA
03/2024
1Polysaccharides (Glycans)IBA
03/2024
1Mannose (D-Mannose)IBA
03/2024
1RNA (Ribonucleic Acid)IBA
01/2023
1InterferonsIBA
01/2023
1Cell-Penetrating PeptidesIBA
08/2021
1CrizotinibIBA
02/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017
1thiamine triphosphorate (TTP)IBA
07/2017
1pevonedistatIBA
05/2016
1AntibodiesIBA
09/2015
1Oncogene Proteins (Oncogene Protein)IBA
09/2015
1Epidermal Growth Factor (EGF)IBA
02/2014
1Antineoplastic Agents (Antineoplastics)IBA
02/2014
1C-terminal binding proteinIBA
10/2012
1Co-Repressor ProteinsIBA
10/2012
1Monoclonal AntibodiesIBA
08/2012
1LuciferasesIBA
10/2011
1Bortezomib (Velcade)FDA Link
09/2011
1Caspase 3 (Caspase-3)IBA
06/2011
1UbiquitinIBA
04/2010
1Ligases (Synthetase)IBA
04/2010
1AndrogensIBA
11/2009
1Proto-Oncogene Proteins c-etsIBA
11/2009
1DNA (Deoxyribonucleic Acid)IBA
11/2009
15' Untranslated Regions (5' UTR)IBA
11/2009
1Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2009
1TransferasesIBA
02/2009
1Amino AcidsFDA Link
02/2009
1Radiation-Sensitizing AgentsIBA
09/2007
1Histone Deacetylase InhibitorsIBA
09/2007
1Histone Deacetylases (Histone Deacetylase)IBA
09/2007
1Histones (Histone)IBA
09/2007
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2007
1Mitogen-Activated Protein Kinase 3IBA
12/2006
1Mitogen-Activated Protein Kinase PhosphatasesIBA
12/2006
1Propidium (Propidium Iodide)IBA
07/2006
1tyrosine receptor (receptor, tyrosine)IBA
01/2004
1Canertinib (CI 1033)IBA
01/2004
1beta-Galactosidase (Lactaid)IBA
02/2003
1Carcinoembryonic AntigenIBA
04/2002

Therapy/Procedure

11Therapeutics
03/2024 - 04/2002
10Radiotherapy
01/2023 - 01/2004
3Aftercare (After-Treatment)
09/2013 - 09/2007
1Injections
08/2021
1Drug Therapy (Chemotherapy)
10/2015
1Intraperitoneal Injections
02/2014
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
09/2011
1Combined Modality Therapy
01/2010
1Chemoradiotherapy
04/2007